Anti-Gcn1l1抗体(ab86139)

概述

  • 产品名称Anti-Gcn1l1抗体
  • 描述
    兔多克隆抗体to Gcn1l1
  • 经测试应用适用于: ICC/IF, WB, IP, IHC-Pmore details
  • 种属反应性
    与反应: Mouse, Rat, Human
    预测可用于: Rabbit, Horse, Cow, Pig, Chimpanzee, Gorilla, Bat, Elephant
  • 免疫原

    A region between residue 2621 and 2671 of human Gcn1l1 using the numbering given in entry NP_006827.1.

  • 阳性对照
    • HeLa cytoplasmic lysate 293T cytoplasmic lysate

性能

  • 形式Liquid
  • 存放说明Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • 存储溶液Preservative: 0.09% Sodium Azide
    Constituents: 0.1% BSA, Tris buffered saline
  • Concentration information loading...
  • 纯度Immunogen affinity purified
  • 克隆多克隆
  • 同种型IgG
  • 研究领域

应用

Our Abpromise guarantee covers the use of ab86139 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
ICC/IF Use a concentration of 1 µg/ml.
WB 1/2000 - 1/10000. Predicted molecular weight: 293 kDa.
IP Use at 2-5 µg/mg of lysate.
IHC-P Use a concentration of 5 µg/ml. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

靶标

  • 功能Acts as a positive activator of the EIF2AK4/GCN2 protein kinase activity in response to amino acid starvation. Forms a complex with EIF2AK4/GCN2 on translating ribosomes; during this process, GCN1 seems to act as a chaperone to facilitate delivery of uncharged tRNAs that enter the A site of ribosomes to the tRNA-binding domain of EIF2AK4/GCN2, and hence stimulating EIF2AK4/GCN2 kinase activity. Participates in the repression of global protein synthesis and in gene-specific mRNA translation activation, such as the transcriptional activator ATF4, by promoting the EIF2AK4/GCN2-mediated phosphorylation of eukaryotic translation initiation factor 2 (eIF-2-alpha/EIF2S1) on 'Ser-52', and hence allowing ATF4-mediated reprogramming of amino acid biosynthetic gene expression to alleviate nutrient depletion.
  • 组织特异性Ubiquitously expressed (PubMed:9039502). Expressed in skeletal muscules, ovary and testis (PubMed:9234705).
  • 序列相似性Belongs to the GCN1 family.
    Contains 47 HEAT repeats.
  • 细胞定位Cytoplasm. Associates with ribosomes in undifferentiated neuroblastoma cells and increases after neuronal differentiation.
  • Information by UniProt
  • 数据库链接
  • 别名
    • eIF-2-alpha kinase activator GCN1 antibody
    • GCN1 (general control of amino acid synthesis yeast homolog) like antibody
    • GCN1 (general control of amino acid synthesis 1 yeast) like 1 antibody
    • GCN1 antibody
    • GCN1 eIF-2-alpha kinase activator homolog antibody
    • GCN1 general control of amino acid synthesis 1 like 1 antibody
    • GCN1 general control of amino acid synthesis 1 like 1 (yeast) antibody
    • GCN1 like protein 1 antibody
    • GCN1-like protein 1 antibody
    • GCN1_HUMAN antibody
    • GCN1L antibody
    • General control of amino-acid synthesis 1-like protein 1 antibody
    • HsGCN1 antibody
    • Translational activator gcn1 antibody
    see all

Anti-Gcn1l1 antibody 图像

  • All lanes : Anti-Gcn1l1 antibody (ab86139) at 0.04 µg/ml

    Lane 1 : HeLa whole cell lysate at 50 µg
    Lane 2 : HeLa whole cell lysate at 15 µg
    Lane 3 : HeLa whole cell lysate at 5 µg
    Lane 4 : 293T whole cell lysate at 50 µg

    Developed using the ECL technique

    Predicted band size : 293 kDa
    Observed band size : 293 kDa


    Exposure time : 30 seconds
  • Detection of Human Gcn1l1 by Immunoprecipitation, using ab86139 at 3µg/mg lysate. Image shows immunoprecipitated Gcn1l1 detected with post IP WB, loading 20% of IP and using HeLa whole cell lysate at 1mg, with ab86139 at 1 µg/ml in lane 1 and control IgG in lane 2. Detection: Chemiluminescence with an exposure time of 30 seconds.
  • ICC/IF image of ab86139 stained HeLa cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab86139, 1µg/ml) overnight at +4°C. The secondary antibody (green) was ab96899, DyLight® 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

  • IHC image of ab86139 staining in human breast carcinoma formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab86139, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

    For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Anti-Gcn1l1 antibody (ab86139)参考文献

ab86139 has not yet been referenced specifically in any publications.

Product Wall

Application Immunocytochemistry/ Immunofluorescence
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 3% · Temperature: 22°C
Sample Human Cell (293T)
Specification 293T
Permeabilization Yes - 0.5% Triton X100
Fixative Paraformaldehyde
Username

Abcam user community

Verified customer

提交于 Sep 19 2014

Application Western blot
Loading amount 20 µg
Gel Running Conditions Reduced Denaturing (4-12 Bis tris)
Sample Human Cell lysate - whole cell (293T)
Specification 293T
Blocking step Milk as blocking agent for 12 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 22°C
Username

Abcam user community

Verified customer

提交于 Sep 19 2014

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"